In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia-Reference-Cited by-同舟云学术

In Vitro and In Vivo Characterization of the Non-peptide NK3 Receptor Antagonist SB-223412 (Talnetant): Potential Therapeutic Utility in the Treatment of Schizophrenia

Published:2007-08-29 Issue:7 Volume:33 Page:1642-1652
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Dawson Lee A,Cato Katherine J,Scott Claire,Watson Jeannette M,Wood Martyn D,Foxton Richard,de la Flor Raúl,Jones Gareth A,Kew James NC,Cluderay Jane E,Southam Eric,Murkitt Graham S,Gartlon Jane,Pemberton Darrel J,Jones Declan NC,Davies Ceri H,Hagan Jim

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/1301549.pdf

Reference44 articles.

1. Alonso R, Fournier M, Carayon P, Petitpretre G, Le Fur G, Soubrie P (1996). Evidence for the modulation of dopamine-neuronal function by tachykinin NK3 receptor stimulation in gerbils. Eur J Neurosci 8: 801–808.

2. Ames R, Fornwald J, Nuthulaganti P, Trill J, Foley J, Buckley P et al (2004). BacMam recombinant baculoviruses in G protein-coupled receptor drug discovery. Receptors Channels 10: 99–107.

3. Bannon MJ, Lee J-M, Giraud P, Young A, Affolter HU, Bonner TI (1986). The dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. J Biol Chem 261: 6640–6642.

4. Bert L, Rodier D, Bougault I, Allouard N, Le Fur G, Soubrie P et al (2002). Permissive role of neurokinin NK3 receptors in NK1 receptor-mediated activation of the locus coeruleus revealed by SR-142801. Synapse 43: 62–69.

5. Blaney FE, Raveglia LF, Artico M, Cavagnera S, Dartois C, Farina C et al (2001). Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists. J Med Chem 44: 1675–1689.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of a Deep Mouse Brain Spectral Library for Transmembrane Proteome Profiling in Mental Disease Models;Molecular & Cellular Proteomics;2024-06

2. Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia;CNS & Neurological Disorders - Drug Targets;2023-08

3. Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons;Neuropeptides;2023-06

4. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders;Signal Transduction and Targeted Therapy;2023-05-03

5. Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist–Neurokinin Antagonist Peptidomimetics;Molecules;2021-09-06